(19)
(11) EP 1 716 257 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
07.11.2012 Bulletin 2012/45

(45) Mention of the grant of the patent:
20.10.2010 Bulletin 2010/42

(21) Application number: 05715271.2

(22) Date of filing: 08.02.2005
(51) International Patent Classification (IPC): 
C12Q 1/70(2006.01)
(86) International application number:
PCT/EP2005/001243
(87) International publication number:
WO 2005/075686 (18.08.2005 Gazette 2005/33)

(54)

NEW PRIMERS AND PROBES FOR THE DETECTION OF PARVOVIRUS B19

NEUE PRIMER UND SONDEN ZUM NACHWEIS VON PARVOVIRUS B19

NOUVELLES AMORCES ET SONDES POUR LA DÉTECTION DU PARVOVIRUS B19

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 10.02.2004 EP 04002854

(43) Date of publication of application:
02.11.2006 Bulletin 2006/44

(60) Divisional application:
10161839.5 / 2251441

(73) Proprietors:
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)
    Designated Contracting States:
    DE 
  • F.Hoffmann-La Roche AG
    4070 Basel (CH)
    Designated Contracting States:
    AT BE BG CH CY CZ DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR 

(72) Inventor:
  • SCHORLING, Stefan
    82377 Penzberg (DE)

(74) Representative: Herren, Barbara et al
Roche Diagnostics AG Patent Department Forrenstrasse
6343 Rotkreuz
6343 Rotkreuz (CH)


(56) References cited: : 
WO-A-99/28439
   
  • SCHMIDT I ET AL: "Parvovirus B19 DNA in plasma pools and plasma derivatives." VOX SANGUINIS. NOV 2001, vol. 81, no. 4, November 2001 (2001-11), pages 228-235, XP002288712 ISSN: 0042-9007
  • HARDER T C ET AL: "New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections" JOURNAL OF CLINICAL MICROBIOLOGY 2001 UNITED STATES, vol. 39, no. 12, 2001, pages 4413-4419, XP002288713 ISSN: 0095-1137
  • AUBIN J T ET AL: "Large-scale screening for human parvovirus B19 DNA by PCR: Application to the quality control of plasma for fractionation" VOX SANGUINIS, vol. 78, no. 1, February 2000 (2000-02), pages 7-12, XP002288714 ISSN: 0042-9007
  • MUELLER J ET AL: "Development and validation of a real-time PCR assay for routine testing of blood donations for parvovirus B19 DNA." INFUSION THERAPY AND TRANSFUSION MEDICINE, vol. 29, no. 5, September 2002 (2002-09), pages 254-258, XP008032754 ISSN: 1424-5485
  • GRUBER FRANZ ET AL: "Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection" APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 67, no. 6, June 2001 (2001-06), pages 2837-2839, XP002288716 ISSN: 0099-2240
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).